Related Experiment Video
Updated: Jul 14, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
[The frequency of viral hepatitis C in patients with porphyria cutanea tarda]
L Malina1, P Arenberger, J Kracíková
1Dermatovenerologická klinika 3. LF UK a Transfuzní odd. FN, Praha.
Background:
High frequency of hepatitis C virus antibodies was recently ascertained in chronic hepatic porphyria in several European countries. Some authors correlate these findings with the development of PCT, considering hepatitis C-infection further factor capable of triggering clinical and laboratory manifestation of this enzymopathy. The task of the present work was to ascertain the frequency of HCV antibodies in PCT in Czech Republic by examining an extensive group of patients, followed at the porphyria-advise center.
Methods And Results:
The frequency of HCV antibodies was investigated in 92 PCT-patients with the second-generation enzymatic ELISA method. At the same time, urinary porphyrin excretion and liver function tests were examined in these subjects. Simultaneously also the results of liver biopsy performed at the first presentation of the patients were taken into account. Statistically significant increase of anti-HCV antibodies (21.7%) was found in PCT-group in comparison with the results of the group of healthy blood donors (0.16%).
Conclusions:
HCV-infection might possibly be a factor responsible for the development of PCT in case of proven time-dependent link between the existence of its active viraemic phase and initial symptoms of porphyria. Such an evidence has not been provided yet and remains a task for future studies.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis II: Pathophysiology

